Zebrafish ( ) mutants provide a preclinical model for macular corneal dystrophy

Esra Ersoz-Gulseven,Merve Basol,Helin Özaktaş,Sibel Kalyoncu,Canan Asli Utine,Gulcin Cakan-Akdogan
DOI: https://doi.org/10.1101/2024.01.24.577150
2024-01-25
Abstract:Macular corneal dystrophy (MCD) is a rare congenital disease caused by mutations in the ( ) gene. Patients suffer from opaque aggregates in the cornea leading to bilateral progressive vision loss by 4 decade of life. Corneal transplantation is the only available treatment, which is invasive, not available to every patient and recurrence of the symptoms is common. Keratocytes in the cornea express the gene, which encodes a golgi enzyme that is essential for sulfation of the keratan sulfate proteoglycans (KSPG). The loss of KS sulfation leads to defects in collagen fibril organization and aggregate formation in the corneal extracellular matrix. Lack of preclinical disease models is a major limitation for the development of accessible treatment strategies. Attempts to develop mouse MCD models have failed due to lack of gene in mice and difference in proteoglycan composition of the mouse cornea. The zebrafish gene has not been studied previously. Zebrafish cornea structure is highly similar to humans, containing high levels of keratan sulfate proteoglycans in the stroma. Here, loss of function mutant zebrafish were generated with CRISPR/Cas9 mediated gene editing. Several alleles were obtained, and loss of KSPG sulfation in the eye stroma was shown. Mutant zebrafish developed age-dependent, alcian blue positive, opaque accumulates in the cornea. Degeneration of corneal structure and changes in epithelial thickness were observed. The zebrafish MCD model developed here is the first model of the disease and opens up possibilities to develop and screen treatment strategies.
Molecular Biology
What problem does this paper attempt to address?